Munich-based medtech startup Symphera has successfully raised €2.4 million in Seed funding to revolutionize laparoscopic surgery. The company's cutting-edge surgical systems automate tool-switching, eliminating the need for manual instrument changes and streamlining the entire procedure.
With Symphera's technology, surgeons can effortlessly switch between instruments with the push of a button—similar to using a multipen—allowing them to focus entirely on the operation. This innovation is designed to enhance surgical workflows, reduce operation times, and improve patient outcomes.
The Seed round, spearheaded by High-Tech Gründerfonds (HTGF), also saw contributions from Bayern Kapital, CARMA FUND, UnternehmerTUM Funding for Innovators, and Stern Stewart Ventures. International support came from IRCAD in Strasbourg and notable business angels in the medical sector.
Prof. Jacques Marescaux, Founder and President of IRCAD, highlighted the impact of Symphera’s technology: “At IRCAD, we are constantly seeking breakthroughs that can transform minimally invasive surgery. Symphera’s tool-switching innovation is truly revolutionary, and we are thrilled to support its journey to operating rooms worldwide.”
Dr. Jan Engels, Investment Manager at HTGF, added, “Symphera’s approach addresses the full range of laparoscopy, from standard workflows to advanced robot-assisted applications. The company represents a compelling opportunity in an exciting field.”
With this new funding, Symphera is poised to advance its product development, begin pre-clinical testing, and prepare for certification. These critical steps will bring their groundbreaking technology closer to market, aiming to reshape laparoscopic surgery and enhance patient care.
